ANTIHEMOPHILIC FACTOR VIII (RECOMBINANT, B-DOMAIN TRUNCATED), PEGYLATED — all Canadian products
5 DINs
5 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is ANTIHEMOPHILIC FACTOR VIII (RECOMBINANT, B-DOMAIN TRUNCATED), PEGYLATED, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02490064 | ESPEROCT | NOVO NORDISK CANADA INC | Powder For Solution | Intravenous | ANTIHEMOPHILIC FACTOR VIII (RECOMBINANT, B-DOMAIN TRUNCATED), PEGYLATED 500 UNIT | Marketed | |
| 02490072 | ESPEROCT | NOVO NORDISK CANADA INC | Powder For Solution | Intravenous | ANTIHEMOPHILIC FACTOR VIII (RECOMBINANT, B-DOMAIN TRUNCATED), PEGYLATED 1000 UNIT | Marketed | |
| 02490080 | ESPEROCT | NOVO NORDISK CANADA INC | Powder For Solution | Intravenous | ANTIHEMOPHILIC FACTOR VIII (RECOMBINANT, B-DOMAIN TRUNCATED), PEGYLATED 1500 UNIT | Approved | |
| 02490099 | ESPEROCT | NOVO NORDISK CANADA INC | Powder For Solution | Intravenous | ANTIHEMOPHILIC FACTOR VIII (RECOMBINANT, B-DOMAIN TRUNCATED), PEGYLATED 2000 UNIT | Marketed | |
| 02490102 | ESPEROCT | NOVO NORDISK CANADA INC | Powder For Solution | Intravenous | ANTIHEMOPHILIC FACTOR VIII (RECOMBINANT, B-DOMAIN TRUNCATED), PEGYLATED 3000 UNIT | Marketed |
Browse other molecules: